Krintafel™ and the nigerian niger-delta region: The unheard story of the purported wonder drug

BACKGROUND: The July 2018 declaration of discovery of Krintafel™ , the first single-dose anti-malarial agent to prevent P. Vivax relapse, was clearly a significant step in pharmaceutical efforts geared towards malaria eradication. How much of the medical dialogue contained in that declaration trickl...

Full description

Bibliographic Details
Main Author: Enaohwo Mamerhi Taniyohwo
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Nigerian Journal of Medicine
Subjects:
Online Access:http://www.njmonline.org/article.asp?issn=1115-2613;year=2019;volume=28;issue=2;spage=152;epage=155;aulast=Taniyohwo;type=0

Similar Items